©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 113475
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113475
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113475
Table 4 Diagnostic performance of the indices for the differentiation of F3 and F4 from lower stages
| Indices | AUC | P value | Sensitivity | Specificity | PPV (%) | NPV (%) | DA (%) |
| FIB-4 | 0.806 | 0.000 | 0.692 | 0.804 | 72.97 | 77.36 | 75.63 |
| APRI | 0.772 | 0.000 | 0.820 | 0.627 | 62.75 | 82.05 | 71.21 |
| NLR | 0.540 | 0.512 | 0.462 | 0.706 | 54.55 | 63.16 | 60.00 |
| PLR | 0.301 | 0.001 | 0.051 | 0.980 | 66.67 | 57.47 | 58.43 |
| NPAR | 0.673 | 0.005 | 0.615 | 0.745 | 64.86 | 71.7 | 68.88 |
- Citation: Joseph A, Mathew S, Nair HR. Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; 18(1): 113475
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/113475.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.113475